

Enter your email to stay informed about occasional coupons and promotions. We only send emails when there’s something worth sharing.
$62.00
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
ARA290, an alternative of erythropoietin, is a synthetic peptide that has attracted significant interest in biomedical and laboratory research. Unlike erythropoietin, which primarily stimulates red blood cell production, ARA290 provides tissue protection and neuroprotective benefits. Researchers studying ARA290, an alternative of erythropoietin, aim to understand its unique mechanism of action, optimal dosing strategies, and potential applications in nerve injury, inflammation reduction, and tissue repair.
ARA290 works by selectively activating specific receptors that trigger protective cellular pathways without affecting hematocrit levels. This makes ARA290, an alternative of erythropoietin, a highly valuable peptide for preclinical studies. Laboratory investigations focus on its role in neuroprotection, immune modulation, and enhanced wound healing, allowing researchers to explore alternative therapeutic strategies safely.
Provides tissue protective and neuroprotective effects in preclinical studies
Does not increase red blood cell production, unlike erythropoietin
Effective for studying nerve injury, inflammation, and tissue repair models
Well-documented in laboratory experiments
Helps researchers analyze receptor-specific signaling pathways and peptide pharmacology
Limited human clinical studies; primarily intended for laboratory research
Requires proper storage, handling, and safety protocols in research settings
Potential side effects in experimental models are still under investigation
Strictly for research purposes; not for human use
Studying ARA290, an alternative of erythropoietin, provides critical insights into tissue repair mechanisms, receptor activation, and neuroprotective signaling. Its non-hematopoietic properties make it an attractive alternative to erythropoietin in preclinical research. These studies help scientists evaluate the peptide’s potential in inflammation modulation, nerve protection, and tissue regeneration, contributing valuable data to biomedical research.
For additional scientific details, visit ARA290 on Wikipedia
Internal reference: Explore related peptides at MyGLP1 Store
All ARA290 products from MyGLP1 Store are strictly for laboratory research purposes and not for human consumption or clinical use. Always follow proper lab safety and handling protocols.
ARA290, an alternative of erythropoietin, is a synthetic peptide that has attracted significant interest in biomedical and laboratory research. Unlike erythropoietin, which primarily stimulates red blood cell production, ARA290 provides tissue protection and neuroprotective benefits. Researchers studying ARA290, an alternative of erythropoietin, aim to understand its unique mechanism of action, optimal dosing strategies, and potential applications in nerve injury, inflammation reduction, and tissue repair.
ARA290 works by selectively activating specific receptors that trigger protective cellular pathways without affecting hematocrit levels. This makes ARA290, an alternative of erythropoietin, a highly valuable peptide for preclinical studies. Laboratory investigations focus on its role in neuroprotection, immune modulation, and enhanced wound healing, allowing researchers to explore alternative therapeutic strategies safely.
Provides tissue protective and neuroprotective effects in preclinical studies
Does not increase red blood cell production, unlike erythropoietin
Effective for studying nerve injury, inflammation, and tissue repair models
Well-documented in laboratory experiments
Helps researchers analyze receptor-specific signaling pathways and peptide pharmacology
Limited human clinical studies; primarily intended for laboratory research
Requires proper storage, handling, and safety protocols in research settings
Potential side effects in experimental models are still under investigation
Strictly for research purposes; not for human use
Studying ARA290, an alternative of erythropoietin, provides critical insights into tissue repair mechanisms, receptor activation, and neuroprotective signaling. Its non-hematopoietic properties make it an attractive alternative to erythropoietin in preclinical research. These studies help scientists evaluate the peptide’s potential in inflammation modulation, nerve protection, and tissue regeneration, contributing valuable data to biomedical research.
For additional scientific details, visit ARA290 on Wikipedia
Internal reference: Explore related peptides at MyGLP1 Store
All ARA290 products from MyGLP1 Store are strictly for laboratory research purposes and not for human consumption or clinical use. Always follow proper lab safety and handling protocols.
WhatsApp us
Reviews
There are no reviews yet.